This is a work of the US government and distributed under the terms of the Public Domain
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Abstract
Introduction:
1-Bromopropane (CAS No. 106-94-5) is a brominated hydrocarbon currently used as a solvent in a variety of industrial and commercial applications. Workers are exposed to 1-bromopropane from its production and use as an adhesive (highest levels), an aerosol solvent, and a vapor degreaser, and in dry cleaning. Several of these uses resulted from the substitution of bromopropane for substances identified as suspected carcinogens or ozone-depleting chemicals. People living near industrial facilities may be exposed to 1-bromopropane, albeit at lower levels than via occupational exposure.
Methods: The National Toxicology Program (NTP) evaluated evidence for cancer studies in experimental animals and mechanisms of carcinogenesis by evaluating study quality and integrating evidence across studies. Using established criteria, NTP reached conclusions on the strength of evidence for the carcinogenicity of 1-bromopropane; the final listing recommendation was reached by applying Report on Carcinogens (RoC) listing criteria to the body of evidence. Some information on worker exposure is available but no epidemiological studies or case reports were identified that evaluated the relationship between human cancer and exposure specifically to 1-bromopropane.
Results and Discussion
Cancer studies in experimental animals:
NTP concluded that there was sufficient evidence of carcinogenicity in animals based on its review of studies, which showed that inhalation exposure to 1-bromopropane caused tumors in two rodent species and at several different tissue sites. In male rats, 1-bromopropane caused significant dose-related increases in the incidences of several types of benign and/or malignant skin tumors. Both female and male rats showed an increased incidence of large-intestine tumors, which are rare tumors in rats. In female mice, 1-bromopropane caused significant dose-related increases in the incidence of benign and malignant lung tumors.
Mechanistic data:
Exposure to 1-bromopropane has been shown to cause molecular alterations related to carcinogenicity, including genotoxicity (mutations and DNA damage), oxidative stress, glutathione depletion, and immunomodulation. Reactive metabolites (or intermediates) of 1-bromopropane may be responsible for some of the carcinogenic effects observed in rodents. 1-Bromopropane can bind to macromolecules; it formed S-propylcysteine–globin adducts in exposed animals and humans. Studies showed it caused mutations in cultured mammalian cells with or without addition of mammalian metabolic activation and DNA damage in cultured human cells without metabolic activation. There is limited evidence of DNA damage in leukocytes from 1-bromopropane-exposed workers. Glutathione is an important cellular defense mechanism, and its reduction can lead to oxidative stress, increased toxicity, and carcinogenicity; numerous studies have shown 1-bromopropane induces both oxidative stress and glutathione depletion. Recent studies have shown 1-bromopropane causes immunosuppression in rodents as well as dose-related increases in gene expression and production of proinflammatory cytokines in mouse macrophages and an inflammatory response in rats.
Human cancer studies:
No epidemiological studies or case reports were identified that evaluated the relationship between human cancer and exposure specifically to 1-bromopropane. NTP concluded that the data available from exposure studies in humans were inadequate to evaluate the relationship between human cancer and exposure to 1-bromopropane.
NTP Cancer Hazard Conclusion:
The conclusion of the cancer hazard evaluation was that 1-bromopropane should be listed as reasonably anticipated to be a human carcinogen in the RoC. The Secretary of Health and Human Services approved the listing of 1-bromopropane in the 13th RoC. The rationale for the listing was sufficient evidence of carcinogenicity of 1-bromopane from studies in experimental animals.
Contents
- Foreword
- Collaborators
- Contributors
- Peer Review
- Publication Details
- Introduction and Methods
- 1. Properties and Human Exposure
- 1.1. Chemical Identification and Properties
- 1.2. Uses and Production
- 1.3. Biological Indices of Exposure
- 1.4. Characterization of Exposure in the Workplace
- 1.5. Potential for Environmental Exposure
- 1.6. Potential for Exposure from Other Sources: Consumer Products
- 1.7. Exposure Levels for People
- 1.8. Synthesis and Summary
- 2. Disposition and Toxicokinetics
- 3. Human Cancer Studies
- 4. Studies of Cancer in Experimental Animals
- 5. Mechanistic Data and Other Relevant Effects
- 6. Overall Cancer Hazard Evaluation – Synthesis of Animal, Human, and Mechanistic Data
- References
- Abbreviations
- Glossary
- Appendix A. Literature Search Strategy
- Appendix B. Human Exposure Tables and Regulations and Guidelines
- Appendix C. Assessment of the Quality of the Individual Animal Cancer Studies
- Appendix D. Genotoxicity Studies
- Appendix E. Relevant Toxicological Effects
About the Series
- NLM CatalogRelated NLM Catalog Entries
- Report on Carcinogens Monograph on Cumene: RoC Monograph 02.[Rep Carcinog Monogr. 2013]Report on Carcinogens Monograph on Cumene: RoC Monograph 02.National Toxicology Program. Rep Carcinog Monogr. 2013 Sep; (02):1-166.
- Toxicology and carcinogenesis studies of 1-bromopropane (CAS No. 106-94-5) in F344/N rats and B6C3F1 mice (inhalation studies).[Natl Toxicol Program Tech Rep ...]Toxicology and carcinogenesis studies of 1-bromopropane (CAS No. 106-94-5) in F344/N rats and B6C3F1 mice (inhalation studies).National Toxicology Program. Natl Toxicol Program Tech Rep Ser. 2011 Aug; (564):1-190.
- 28-Day somatic gene mutation study of 1-bromopropane in female Big Blue(®) B6C3F1 mice via whole-body inhalation: Support for a carcinogenic threshold.[Regul Toxicol Pharmacol. 2019]28-Day somatic gene mutation study of 1-bromopropane in female Big Blue(®) B6C3F1 mice via whole-body inhalation: Support for a carcinogenic threshold.Stelljes M, Young R, Weinberg J. Regul Toxicol Pharmacol. 2019 Jun; 104:1-7. Epub 2019 Feb 16.
- Review Report on Carcinogens Monograph on Cobalt and Cobalt Compounds That Release Cobalt Ions In Vivo: RoC Monograph 06[ 2016]Review Report on Carcinogens Monograph on Cobalt and Cobalt Compounds That Release Cobalt Ions In Vivo: RoC Monograph 06National Toxicology Program. 2016 Apr
- Review Report on Carcinogens Monograph on Haloacetic Acids Found as Water Disinfection By-Products: RoC Monograph 12[ 2018]Review Report on Carcinogens Monograph on Haloacetic Acids Found as Water Disinfection By-Products: RoC Monograph 12National Toxicology Program. 2018 Mar
- Report on Carcinogens Monograph on 1-BromopropaneReport on Carcinogens Monograph on 1-Bromopropane
Your browsing activity is empty.
Activity recording is turned off.
See more...